NCT06898645View on ClinicalTrials.gov

Efficacy of Cerebellar Transcranial Magnetic Stimulation to Treat Hereditary Spinocerebellar Ataxias

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Spinocerebellar Ataxias
Interventions
DEVICE

navigated iTBS (Intermittent theta-burst stimulation) targeting the cerebellum

1,800 pulses per session for unilateral cerebellum, 50-minute intersession interval, 80% resting motor threshold, total 75600 pulse number.

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT06898645 - Efficacy of Cerebellar Transcranial Magnetic Stimulation to Treat Hereditary Spinocerebellar Ataxias | Biotech Hunter | Biotech Hunter